AbbVie
AbbVie is a publicly traded research-driven biopharmaceutical company that began as a spinoff from Abbott Laboratories in 2013. With a workforce of roughly 47,000, AbbVie prides itself on coming up with new treatments for chronic conditions and life-threatening illnesses, and its drugs are some of the world’s bestsellers, including cancer treatment Imbruvica and Humira, an immunosuppressant used to treat arthritis and Crohn’s disease. In 2016, AbbVie acquired Stemcentrx for $5.8 billion as part of a campaign to bolster its oncology research division. In 2020, AbbVie completed its purchase of Allergan, an Irish drug manufacturer, for $63 billion.
Courtesy of AbbVie
Lists ranking AbbVie
RANK6
15 Best Large Workplaces in Chicago - 2022Winning workplaces in Chicagoland earned high mark...view in list
RANK72
100 Best Companies to Work For - 2022When it comes to supporting employees, flexibility...view in list
RANK99
100 Best Large Workplaces for Millennials - 2021We surveyed tens of thousands of employees to crea...view in list
World’s Most Admired Companies - 2021After a year in which humanity leaned more heavily...view in list
Latest news for AbbVie
- MagazineBig Hospitals vs. Big Pharma: Which industry is most to blame for soaring health care costs?April 8, 2021 10:30 AM UTC
- HealthIt’s the New Year, and pharma companies are already hiking prices for popular drugsJanuary 4, 2021 8:35 PM UTC
- MPWThree more women have died from cancer linked to Allergan’s recalled breast implants, FDA saysAugust 24, 2020 4:48 PM UTC